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Background/Aims
Breaks in the peristaltic contour on esophageal high-resolution manometry (HRM) may be associated with bolus retention in the 
esophagus. We evaluated the relationship between peristaltic breaks and esophageal symptoms, reflux exposure, and symptom 
outcomes in a prospective patient cohort.
Methods
Two hundred and eighteen patients (53.2 ± 0.9 years, 68.3% female) undergoing both pH-impedance testing and HRM over a 5-year 
period were prospectively evaluated. Demographics, symptom presentation, acid exposure time, symptom association probability, and 
symptom burden scores were collected. Outcomes were assessed on follow-up using changes in symptom scores. Presence of long 
breaks (≥ 5 cm) on HRM was assessed by a blinded author. Relationships between breaks, reflux parameters, presenting symptoms, 
and outcomes were assessed.
Results
Patients with long breaks were more likely to have cough as a presenting symptom than those without (43.4% vs 28.6%, P = 
0.024); statistical differences were not demonstrated with other symptoms (P ≥ 0.3). Numbers of swallows with long breaks were 
higher in patients with cough compared to those without (2.4 ± 0.3 vs 1.6 ± 0.2, P = 0.021); differences were not found with 
other symptoms (P ≥ 0.4). Long breaks were not associated with age, gender, race, reflux burden, symptom association, or changes 
in symptom metrics (P ≥ 0.1 for all comparisons). Among patients with cough, the presence of long breaks predicted suboptimal 
symptom improvement with antireflux therapy (P = 0.018); this difference did not hold true for other symptoms (P ≥ 0.2).
Conclusions
Long breaks in esophageal peristaltic integrity are associated with cough. The presence of long breaks is associated with suboptimal 
benefit from antireflux therapy.
(J Neurogastroenterol Motil 2018;24:387-394)
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Introduction  
Gastroesophageal reflux disease (GERD) commonly presents 
with typical symptoms of heartburn and acid regurgitation, but on 
occasion, can manifest as atypical symptoms, including chest pain, 
cough, and laryngeal symptoms.1 For instance, GERD is the most 
common cause of atypical chest pain not due to a cardiac cause,2 and 
is believed to be the third most common cause triggering chronic 
cough, after post-nasal drip and asthma.3 The likelihood of endo-
scopic evidence of GERD is much lower with atypical symptoms 
when compared to typical symptoms,4 and symptom improvement 
from acid suppressive therapy can be suboptimal.5 Therefore, atypi-
cal symptoms often require evaluation with esophageal physiologic 
tests including ambulatory pH or pH-impedance monitoring (typi-
cally performed off antisecretory therapy in the setting of unproven 
GERD), and esophageal high-resolution manometry (HRM).1
While it is well known that esophageal hypomotility patterns 
are associated with more profound esophageal reflux burden,6 only 
limited evidence points towards association of such patterns with 
specific GERD symptoms. In particular, the presence of weak 
peristalsis with long breaks has been shown to be more prevalent 
in patients with chronic cough when compared to heartburn, with 
evidence of incomplete bolus transit on stationary impedance in the 
setting of breaks.7 The relationship of peristaltic breaks with esopha-
geal symptoms is intriguing, since breaks could potentially allow for 
prolonged retention of bolus or refluxate, and the proximal esopha-
gus is known to be more sensitive to bolus presence.8 However, the 
associations between symptoms, peristaltic breaks, and symptomatic 
outcomes with antireflux therapy remain incompletely understood.
In this study, we evaluated peristaltic breaks on HRM in a 
prospective cohort of patients with reflux symptoms undergoing 
pH-impedance testing, where reflux burden was well characterized, 
and symptom-reflux association was documented. Our aims were: 
(1) to assess the prevalence of abnormal motor patterns, particularly 
breaks in the peristaltic contour, within patients with typical and 
atypical reflux symptoms, (2) to evaluate relationships between 
specific esophageal symptoms, reflux burden, and peristaltic breaks 
on HRM, and (3) to determine if the presence of peristaltic breaks 
predict symptom outcomes with antireflux therapy.
Materials and Methods  
Subjects
All adult patients (≥ 18 years) with persistent GERD symp-
toms despite anti-secretory therapy referred to the Gastroenterol-
ogy Motility Center at Washington University in Saint Louis for 
ambulatory pH-impedance testing and HRM from January 2005 
through August 2010 were eligible for inclusion. Exclusion criteria 
included inadequate studies (poor data quality precluding analysis), 
incomplete studies (< 14 hours recording time for pH-impedance, 
inadequate swallow complement on HRM), presence of major 
esophageal motor disorders (achalasia spectrum disorders, so-
called “scleroderma esophagus”), and history of fundoplication or 
other foregut surgery. Patients were identified from our institution’s 
database and contacted for informed consent; they were prospec-
tively followed up and repeat symptom assessment was performed 
by questionnaire. Patient management was not influenced by this 
study protocol; instead, management was directed by the referring 
physicians. The data-set from which this analysis was performed 
has been previously utilized in analyzing GERD phenotypes,9 and 
in identifying metrics from pH-impedance testing that predict 
GERD symptom response.10,11 This study protocol was approved 
by the Human Research Protection Office (institutional review 
board) at Washington University in Saint Louis (201105490 ap-
proved 6/6/2011). Informed consent was obtained from each pa-
tient for collection and analysis of HRM, and pH-impedance and 
symptom questionnaire data.
High-resolution Manometry
HRM studies were performed after an overnight fast using a 
36-channel solid-state catheter system with high-fidelity circumfer-
ential sensors 1 cm apart along the catheter (Covidien/Given Imag-
ing, Duluth, GA, USA). After calibration, the catheter was passed 
through an anesthetized nasal canal. A 20-second swallow-free pe-
riod was obtained while the subject remained still, resting quietly in 
the recumbent position (landmark period) from which basal pres-
sures were obtained.12 Ten swallows were recorded using 4-5 mL 
of ambient temperature water spaced > 20 seconds apart. Studies 
were acquired and analyzed using dedicated computerized HRM 
acquisition, display, and analysis systems (ManoView; Covidien/
Given Imaging). A blinded author reviewed HRM studies for 
presence and length of breaks in the peristaltic contour of individual 
swallows, using the 20 mm isobaric contour tool. Since this study 
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was designed to evaluate the role of long breaks, any presence of 
breaks, and particularly breaks ≥ 5 cm were recorded (in contrast 
to the Chicago classification v3.0 where breaks are not evaluated if 
distal contractile integral (DCI) < 450 mmHg∙cm∙sec).13 Swallows 
with long breaks (breaks ≥ 5 cm in length) were designated as ei-
ther fragmented (DCI > 450 mmHg∙cm∙sec) or ineffective (DCI 
< 450 mmHg∙cm∙sec) according to the Chicago Classification v3.0 
(Fig. 1).13
pH-Impedance Monitoring
pH-impedance testing was offered in an “open-access” fashion 
such that referring physicians decided whether testing was per-
formed on or off antisecretory therapy. Patients tested off therapy 
were asked to stop their proton pump inhibitor (PPI) medications 
5-7 days prior to the study, and histamine-2 receptor antagonists, 
prokinetic medications, and antacids 3 days prior to the study. 
After an overnight fast, an experienced nurse positioned the pH-
impedance catheter (Sandhill Scientific, Highlands Ranch, CO, 
USA) with the distal esophageal pH sensor placed 5 cm proximal 
to the lower esophageal sphincter, measured using HRM. During 
the data acquisition period, patients recorded meals and activities on 
a paper diary and logged symptom events electronically using the 
device data recorder. Data were then analyzed with dedicated soft-
ware (Bioview Analysis, Sandhill Scientific, Highlands Ranch, CO, 
USA) with automated calculation of acid exposure time (AET), 
reflux episodes, symptom events, and symptom-reflux association 
parameters. Each pH-impedance study was scrutinized manually 
by 2 reviewers (Amit Patel and C Prakash Gyawali) to ensure the 
accuracy of automated capture of reflux events; any discrepancies 
between the reviewers were resolved by discussion. 
Since study patients had pH-impedance studies performed 
both on and off PPI therapy, symptom reflux correlation was first 
assessed. Symptoms were considered associated with reflux events if 
they occurred within 2 minutes following a reflux event. Symptom 
associated probability (SAP) was calculated using the Ghillebert 
probability estimate.14 SAP was designated positive if the likelihood 
of a chance association between symptoms and reflux events was < 
5%, corresponding to P < 0.05 and SAP > 95%. The SAP was 
first calculated for pH-detected reflux events, then re-calculated 
for all impedance-detected reflux events. Our group has previously 
shown that Ghillebert probability estimate correlates very well with 
SAP calculated using the Weusten method, with sensitivity of 0.95 
and specificity of 0.91.15,16 AET was also recorded, calculated as the 
percentage of time the pH was below 4 at the distal esophageal pH 
sensor.10,17
Symptom Burden
Patients reported symptom burden prior to pH-impedance 
monitoring both for dominant presenting symptom and global 
esophageal symptoms. Symptom frequency and severity were rated 
on 5-point Likert scales generated a priori for esophageal testing 
at our center and validated for assessment of esophageal symp-
tom.10,11,18,19 For each esophageal symptom, patients rated symptom 
frequency from 0 (no symptoms) to 4 (very severe symptoms); the 
product of severity and frequency yielded a total score from 0 to 16. 
We have previously reported this as dominant symptom intensity.10,11 
However, for the purpose of this study, symptom intensity was cal-














Set range Intact Fragmented Ineffective
Break: 6.2 cm
DCI: 730 mmHg cm sec
Break: 13.6 cm
DCI: 396 mmHg cm sec
Figure 1. High-resolution manometry Clouse plots demonstrating (A) intact peristaltic contour in an effective swallow, (B) fragmented sequence 
with a long (> 5 cm) break, and (C) ineffective sequence with a long break.
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gardless of whether the symptom was dominant or secondary, hence 
this is termed esophageal symptom intensity (ESI). Patients rated 
their global symptom severity (GSS) pertaining to the esophagus 
over the previous 2 weeks on a 100-mm visual analog scale. Basic 
demographic data (age, gender, and race) were also collected.
Eligible subjects were prospectively contacted to assess manage-
ment approaches (surgical versus medical therapy) and symptom-
atic outcomes, and post-therapy symptom questionnaire data was 
required for evaluation of treatment outcome. The pre-procedure 
symptom survey was re-administered at this follow-up, and linear as 
well as dichotomous (≥ 50%) improvement in ESI and GSS were 
calculated to quantify symptomatic outcomes. Each patient’s treat-
ing physician guided management with no influence from study 
investigators.
Statistical Methods
Data are reported as the mean ± standard error of the mean 
unless otherwise indicated. Demographics, PPI status on testing, 
baseline symptom burden (ESI and GSS), change in symptom 
burden with treatment, SAP, and presence of specific reflux symp-
toms (heartburn, regurgitation, chest pain, cough, dysphagia, and 
laryngeal symptoms) were compared between patients with and 
without long breaks in the peristaltic contour. Categorical data were 
compared using the χ-squared test, and continuous data were com-
pared using ANOVA, 2-tailed Student’s t test, or Mann-Whitney 
U test as appropriate. In all cases, P < 0.05 was required for statis-
tical significance. All statistical analyses were performed using IBM 
SPSS Statistics V.22.0 (Armonk, NY, USA).
Results  
Of 302 patients undergoing HRM in conjunction with ambu-
latory pH-impedance monitoring for GERD symptoms, inclusion 
criteria were met by 218 patients (53.2 ± 0.9 years, 68.3% female; 
Fig. 2). Presenting symptoms included both typical symptoms 
(heartburn: 64.2%, regurgitation: 48.6%), and atypical symptoms 
(chest pain: 30.7%, cough: 35.8%, dysphagia: 17.4%, laryngeal 
symptoms: 11.0%); 168 patients (77.1%) reported > 1 symptom. 
When dominant symptoms were segregated into typical (123 
[56.4%]) and atypical groups (95 [43.6%]), baseline ESI was 
higher in atypical presentations (P = 0.012; Table 1) but global 
symptom burden was similar between these 2 groups (P = 0.243); 
AET was higher with typical presentations (P = 0.022). There 
were no significant differences in demographic, motor diagnoses 
or pH impedance metrics between patients with and without long 
breaks (P > 0.1 for all comparisons); in particular, we did not dem-
onstrate differences in symptom reflux association metrics between 
patients with and without long breaks.
The relationships between individual presenting symptoms and 
peristaltic breaks were further assessed. Cough was seen more often 
as a presenting symptom in patients tested off PPI therapy (48/111, 
43.2%) compared to those tested on therapy (30/107, 28%; P = 
0.020). Patients with cough tested off PPI had higher total acid ex-
posure times compared to those tested on PPI (5.3 ± 0.8 vs 0.9 ± 
0.3, P < 0.001). Despite this, overall symptom burden was similar 
between patients tested off vs on PPI therapy (ESI: 9.3 ± 0.6 vs 8.8 
302 pH-impedance studies in
5-year study period
84 Patients ineligible
7 incomplete pH-impedance studies
48 incomplete HRM studies
3 motor disorders
26 prior surgery
Atypical symptoms (n = 95)
54.6 + 1.3 yr, 61% F
218 Patients included
53.2 + 0.9 yr, 68.3% F
111 (50.9%) tested off PPI
Typical symptoms (n = 123)
52.1 + 1.1 yr, 74% F
159 Reached for follow-up
54.4 + 1.0, 70% F
Figure 2. Flow chart describing the 
study population. HRM, high-resolu-
tion manometry; F, female; PPI, proton
pump inhibitor.
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± 0.6 respectively, GSS: 62.6 ± 3.0 vs 63.3 ± 2.8 respectively, P 
> 0.6 for each comparison). Further, PPI status had no bearing on 
esophageal motor pattern based on the Chicago classification v3.0 (P 
> 0.8 for each comparison). 
Patients with cough were significantly more likely than those 
without cough to have long breaks in the peristaltic contour (59.0% 
vs 42.8%, P = 0.024; Fig. 3); this did not differ whether testing 
was performed off or on PPI status. The odds ratio of cough as a 
presenting symptom in the setting of breaks was 1.9 (95% confi-
dence interval: 1.1-3.4, P = 0.023); none of the other presenting 
symptoms were similarly associated (odds ratios 0.73-1.03, P ≥ 
0.3). The average number of swallows with long breaks was higher 
in patients with cough compared to patients without cough (2.4 ± 
0.3 vs 1.6 ± 0.2, P = 0.021; Fig. 3). Although the average length 
of peristaltic breaks was similar between patients presenting with 
and without cough (7.6 ± 0.5 cm vs 8.1 ± 0.4 cm, P = 0.496), the 
likelihood of fragmented sequences were higher with cough (21.8% 
vs 10.7%, P =0.044). Despite this, the proportion of patients clas-
sified with ineffective esophageal motility (IEM) was similar. None 
of other typical or atypical presenting symptom was associated with 
breaks in this fashion. Mean DCI, numbers of ineffective swallows, 
and proportions with IEM were similar regardless of presenting 
symptom. Cough patients were slightly older and had higher base-
line symptom burden, but were otherwise similar to patients without 
cough (Table 2).










Age (yr) 52.1 ± 1.1 54.6 ± 1.3 0.151
Gender (% female) 74 61 0.056
Baseline ESI 8.1 ± 0.6 10.3 ± 0.7 0.011
Baseline GSS 60.8 ± 2.7 65.7 ± 3.1 0.243
AET total (%) 4.4 ± 0.5 2.8 ± 0.4 0.022
IEM 37 (30%) 18 (19%) 0.507
Fragmented peristalsis 1 (1%) 1 (1%) > 0.99
Normal peristalsis 85 (69%) 72 (76%) 0.291
Swallows with long breaks 2.0 ± 0.3 1.7 ± 0.3 0.313
ESI, esophageal symptom intensity; GSS, global symptom severity; AET, acid 
















































Figure 3. Proportion of breaks in patients with cough. More patients 
with cough had long (> 5 cm) breaks in the peristaltic contour com-
pared to patients without cough (*P = 0.024). Numbers of swallows 










Odds ratio (95% confidence intervals)
Predictors of linear ESI change
64202468
Figure 4. Predictors of symptom change from antireflux therapy. On 
multi variate linear regression, the presence of long breaks was a pre-
dictor of suboptimal symptom outcome from antireflux therapy in pa-
tients with cough (*P = 0.010). ESI, esophageal symptom intensity; 
PPI, proton pump inhibitor; AET, acid exposure time; SAP, symptom 
association probability.
Table 2. Comparison of Clinical Characteristics Between Patients 







Age (yr) 51.3 ± 1.1 56.7 ± 1.4 0.002
Gender (% female) 67 69 0.762
Baseline ESI 10.5 ± 0.7 8.3 ± 0.5 0.018
Baseline GSS 67.3 ± 3.5 60.4 ± 2.5 0.111
AET total (%) 3.6 ± 0.5 3.7 ± 0.5 0.892
IEM 24 (31%) 35 (25%) 0.427
Fragmented peristalsis 1 (1%) 1 (1%) > 0.99
Normal peristalsis 53 (68%) 100 (71%) 0.644
Swallows with long breaks 2.4 ± 0.3 1.6 ± 0.2 0.031
ESI, esophageal symptom intensity; GSS, global symptom severity; AET, acid 
exposure time; IEM, ineffective esophageal motility.
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Symptom Outcomes
One hundred and fifty-nine patients were successfully con-
tacted to assess symptom outcome after 36.1 ± 1.2 months. Over-
all, ESI decreased by 5.3 ± 0.5 and GSS by 35.2 ± 2.8. Though 
patients with atypical symptoms had a higher baseline ESI than 
those with typical symptoms (10.3 ± 0.7 vs 8.1 ± 0.6, P = 0.012), 
GSS was similar between the groups, and there was no difference 
in degree of improvement in symptom burden with treatment. The 
presence or absence of long breaks did not predict symptom burden 
or change in symptoms in the overall cohort.
Independent of reflux parameters, the presence of long breaks 
with cough as a presenting symptom was a negative predictor for 
ESI change with antireflux therapy (ESI improvement of 4.9 ± 
0.9) compared to patients without long breaks (ESI improvement 
of 8.9 ± 1.4, P = 0.018). GSS improvement was similar regardless 
of the presence of breaks (39.9 ± 5.8 vs 44.6 ± 8.4 respectively, P 
= 0.639). The presence or absence of long breaks did not predict 
improvement in ESI or GSS in a similar fashion with presenting 
symptoms other than cough (P ≥ 0.3 for each comparison).
A multivariate regression model was generated using the pres-
ence of long breaks, age, gender, PPI status, abnormal AET, and 
positive SAP as independent variables, and changes in ESI and 
GSS as the outcome variables. In this model, long breaks retained 
significance as an independent predictor of suboptimal treatment 
outcome within the cough cohort following antireflux therapy, by 
ESI but not GSS (Fig. 4). This significance did not hold true for 
any other typical or atypical reflux symptoms (P ≥ 0.2 for each 
comparison).
Discussion  
In this study, we demonstrate that patients with long breaks in 
the esophageal peristaltic contour on HRM were more likely to 
have cough as a presenting symptom compared to other typical and 
atypical symptoms. Conversely, patients with cough were more like-
ly to have swallows with long breaks in the peristaltic contour, and 
had a higher number of swallows with breaks. These findings were 
independent of esophageal reflux burden, numbers of reflux events, 
or symptom-reflux association with cough events on ambulatory re-
flux monitoring. Our findings validate the report by Almansa et al7 
that weak peristalsis with long breaks is encountered with chronic 
cough; we further report that this association is not replicated with 
other typical or atypical symptoms evaluated with pH-impedance 
monitoring. Finally, our findings suggest that patients with cough 
and long breaks have worse symptomatic outcomes with antireflux 
therapy compared to patients with cough without long breaks, or 
patients with other esophageal symptoms, with or without long 
breaks.
The significance of breaks in the peristaltic contour on esopha-
geal HRM has been extensively debated. The presence of breaks 
on combined HRM and impedance testing has been reported to 
be associated with dysphagia and incomplete bolus clearance20,21; 
in contrast, small breaks are associated with complete bolus clear-
ance and are of questionable clinical significance.22 Weak peristalsis 
with long breaks is reported to be associated with increased acid 
exposure and delayed reflux clearance.6 Although the Chicago clas-
sification v3.0 recognizes long breaks only in the context of DCI > 
450 mmHg∙cm∙sec (fragmented sequences),13 there is evidence to 
suggest that bolus transit is incomplete with long breaks in general, 
regardless of vigor of remnant contraction in the esophagus.7,21 
Both fragmented and ineffective sequences (where DCI < 450 
mmHg∙cm∙sec regardless of breaks) are associated with GERD in 
general, and especially more profound manifestations of GERD 
such as Barrett’s esophagus.23,24 While the Chicago classification 
does not have an IEM category with long breaks, Almansa et al7 
report that this phenotype may be associated with abnormal bolus 
clearance, likely from bolus escape through the break. Our findings 
therefore add to the growing body of evidence supporting a link be-
tween long breaks and esophageal symptoms, particularly in cough 
as a presenting symptom.6,7
The precise mechanism of symptom generation from reflux 
of gastric content is unclear. Both chemical and mechanical recep-
tors participate in reflux symptom generation, especially heartburn 
and chest pain. Cough in particular is thought to have 2 separate 
mechanisms leading to symptom generation–aspiration of reflux-
ate into the trachea (likely infrequent), and triggering of a reflexive 
cough from esophageal stimulation from the refluxate (likely more 
prevalent). Abnormal upper esophageal sphincter function and 
esophageal dysmotility have been correlated with chronic cough 
and positive symptom association in cough patients.25 Using pH-
impedance monitoring, more proximal migration of reflux events 
has been found to be associated with higher perception of heart-
burn and regurgitation.26,27 Afferent sensory nerve endings have 
been demonstrated to be more superficially located in the proximal 
esophagus,8 potentially explaining higher perception in the precise 
area where we report long breaks in the peristaltic contour. Peri-
staltic defects in the transition zone between the proximal and distal 
esophagus are associated with impaired bolus clearance and are 
common regardless of whether IEM is confirmed.28 Therefore, it is 
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possible that breaks are associated with prolonged refluxate contact 
from incomplete reflux clearance in the more perceptive proximal 
esophagus, leading to cough as a symptom. We demonstrate that 
cough patients with breaks in the peristaltic contour have a less 
robust response to antireflux therapy, potentially related to inability 
to clear refluxate despite reduced acid exposure. Our study was 
not designed to evaluate these proposed mechanisms for symptom 
generation, but our findings support a higher likelihood of lack of 
contractile activity in the proximal and mid esophagus in patients 
with cough. 
The current study has a few important limitations. Patients 
included in this cohort were identified retrospectively from the 
original prospectively collected database, and therefore, the study 
is subject to limitations associated with retrospective studies. We 
do not have data on the nature of evaluation of chronic cough, and 
whether all alternate possibilities were rigorously excluded prior to 
esophageal physiologic testing. Symptom-reflux association with 
cough as a presenting symptom is difficult, since patients may not 
activate event monitor buttons in a timely fashion, particularly when 
cough is frequent or paroxysmal29; a cough event monitor was not 
utilized in this study. Patient management was directed by treating 
physicians, and therefore there was no standard protocol employed 
for GERD management, which could have affected our outcome 
data. We also do not have post treatment esophageal function test-
ing to determine if breaks resolved or if pH impedance metrics 
changed in responders in contrast to non-responders. Our patient 
population consists of individuals evaluated at a tertiary care center, 
and therefore our results may not be generalizable to primary care 
populations. Nevertheless, our findings are in concert with prior 
reports linking long breaks to cough as a presenting symptom in the 
setting of reflux evaluation, and therefore support further research 
into understanding the relationship between esophageal symptoms 
and motor patterns.
We conclude that analyzing esophageal motor patterns beyond 
what Chicago classification v3.0 encompasses has clinical utility, 
particularly in the prediction of symptom response in patients with 
cough. What is evident from our findings and other studies in the 
literature is that cough is a complex symptom with links to esopha-
geal motor function. Despite this, treating concurrent reflux does 
not appear sufficient to resolve this symptom. While the precise 
pathophysiologic basis of the association between cough and long 
breaks is unclear, existing esophageal pathophysiologic data may 
imply impaired reflux clearance in triggering symptoms. Further 
prospective research evaluating esophageal symptom generation in 
the context of typical and atypical reflux symptoms is needed.
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